16714-247 : Vancomycin Hydrochloride 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 16714-247
Labeler: Northstar Rx LLC
Product Type: Human Prescription Drug
Drug Name:  Vancomycin Hydrochloride
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA205780
Rev. Date: 


NDC Package Codes:

  • 16714-247-10: 10 VIAL IN 1 CARTON (16714‑247‑10) > 10 ML IN 1 VIAL

Active Ingredients:

  • Vancomycin Hydrochloride

Dosage Strength:

  • 500 mg/10mL

Pharmaceutical Classes:

  • Glycopeptide Antibacterial [EPC]
  • Glycopeptides [CS]

Related Products:

Based on records with the same trade name.
  • 16714-309 Vancomycin Hydrochloride 1 g/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rx LLC
  • 16714-517 Vancomycin Hydrochloride 5 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rx LLC
  • 16714-699 Vancomycin Hydrochloride 10 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rx LLC
  • 0069-2587 Vancomycin Hydrochloride 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-2589 Vancomycin Hydrochloride 1 g/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-2599 Vancomycin Hydrochloride 10 g/100ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-2601 Vancomycin Hydrochloride 10 g/100ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0121-0867 Vancomycin Hydrochloride 125 mg Oral Capsule by Pharmaceutical Associates, Inc.
  • 0121-0890 Vancomycin Hydrochloride 250 mg Oral Capsule by Pharmaceutical Associates, Inc.
  • 0143-9152 Vancomycin Hydrochloride 1.25 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9153 Vancomycin Hydrochloride 1.5 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9161 Vancomycin Hydrochloride 513 mg/mg Intravenous; Oral Injection, Powder, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9162 Vancomycin Hydrochloride 1025 mg/mg Intravenous; Oral Injection, Powder, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9163 Vancomycin Hydrochloride 5.13 g/g Intravenous; Oral Injection, Powder, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9164 Vancomycin Hydrochloride 10.25 g/g Intravenous; Oral Injection, Powder, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9355 Vancomycin Hydrochloride Hydrochloride 750 mg Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9356 Vancomycin Hydrochloride 500 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9357 Vancomycin Hydrochloride 1 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9358 Vancomycin Hydrochloride 5 g/1 Intravenous Injection, Powder, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9359 Vancomycin Hydrochloride 10 g/1 Intravenous Injection, Powder, for Solution by West-ward Pharmaceuticals Corp
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16714-247 QR Code

< Prev: 16714-246Next: 16714-248 >

Related Discussions:

Vancomycin hydrochloride capsule
I would like to know what vancomycin hydrochloride is for? ## Hello, Lucy! How are you? The FDA classifies Vancomycin as... 4 replies
vancomycin HCL
for treatment of virus infection resulting in shingles...
Vancomycin
...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.